U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > global-health-funding-news-2021-0913 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Funding news for global health researchers September 13, 2021

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH News

Important news from NIH for all grantees.

  • Request for Information (RFI): Research Opportunities to End Hunger, Food and Nutrition Insecurity.
    (NOT-OD-21-183)

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

  • Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-21-251)
    Application Receipt Dates: November 3, 2021, November 3, 2022, and November 3, 2023 by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    Note: Fogarty is participating.
  • Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-21-252)
    Application Receipt Dates: November 3, 2021, November 3, 2022, and November 3, 2023 by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    Note: Fogarty is participating.
  • AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) (PAS-21-270)
    Application Receipt Dates: Multiple dates, see announcement.

NIH funding opportunities for which foreign organizations may apply.

  • Utilizing the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) (PAR-21-330)
    Application Receipt Dates: Multiple dates, see announcement
  • Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional) (RFA-DA-22-028)
    Application Receipt Date: February 9, 2022
  • Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional) (RFA-DA-22-039)
    Application Receipt Date: February 9, 2022
  • High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) (RFA-DA-22-040)
    Application Receipt Dates: Multiple dates, see announcement

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • Notice of Special Interest (NOSI): Evaluation of sex differences on HIV-associated comorbidities in the context of stimulant use (NOT-DA-21-020)

Upcoming Deadlines